Technological Adjuncts for Malignant Brain Tumor Surgery

Faculty speak to malignant brain tumor surgery and its technical adjuncts for neurosurgeons in the operating room. Earn 3.0 CME and learn about the strategies for intraoperative diagnosis and imaging, tumor resection, noninvasive catheter-based treatments as well as how to recognize the validity of emerging techniques in intraoperative brain tumor visualization.

Pricing

AANS Member$49
Non-member$79

Faculty

Principal Faculty

  • Manish K. Aghi, MD, PhD, FAANS
  • Daniel A. Orringer, MD, FAANS
  • Kaisorn Lee Chaichana, MD, FAANS
  • Michael A. Vogelbaum, MD, PhD, FAANS
  • Constantinos G. Hadjipanayis, MD, PhD, FAANS
  • Francesco DiMeco, MD, IFAANS
  • Andrew E. Sloan, MD, FAANS
  • Alexandra J. Golby, MD, FAANS

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply technological adjuncts that aid in the intraoperative diagnosis and imaging of malignant brain tumors in the operating room during surgery.
  • Distinguish technological adjuncts that aid in the resection of malignant brain tumors.
  • Demonstrate technological adjuncts that enable noninvasive catheter-based treatments of malignant brain tumors.
  • Appraise technological adjuncts that enable minimally invasive, but complete resection, of malignant brain tumors in the operating room.
  • Recognize the scientific basis and proposed clinical applications of emerging techniques in intraoperative brain tumor visualization. 

CME Accreditation

The AANS designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits™

Disclaimer

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the AANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources, and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care, or course of management does not imply endorsement or disapproval of products.

Please note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients we serve.

Disclosure Information

As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), the AANS must ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. In accordance with the ACCME’s Standards for Commercial Support, the AANS is required to disclose to the activity audience the relevant financial relationships of the planners, faculty and any other individual in a position to control content of this activity.

Please find the relevant financial relationships disclosed below for all individuals in control of content. All conflicts of interest have been resolved in accordance with ACCME Standards for Commercial Support.

Name

Relationship/Company

Daniel A. Orringer, MD, FAANS Consultant Fees – Invenio Imaging, Inc., Stryker     Stock Shareholder (purchased direct) - Invenio Imaging, Inc., Stryker Inc    Board, Trustee, Officer, Leadership position – Stryker Inc
Michael A. Vogelbaum, MD, PhD, FAANSBoard, Trustee, Officer, Leadership position – Infuseon Therapeutics, Inc. Honorarium – Tocagen, Celgene
Constantinos G. Hadjipanayis, MD, PhD, FAANSConsultant Fees – Synaptive Inc. Other Financial Support - NX Development Corp
Francesco DiMeco, MD, IFAANSConsultant Fees – Insightec Board, Trustee, Officer, Leadership position - In.tra Stock Shareholder (purchased direct) – Stemgen
Andrew E. Sloan, MD, FAANSConsultant Fees – Monteris Inc., Surgical Theatre Inc. Other Financial Support – Monteris, Inc Honorarium – Surgical Theatre Inc. Stock Shareholder (purchased direct) – Surgical Theatre Inc., Merck Pharmaceuticals, Inc. Grants/Research Support – Lentigen Inc., PharmacoKinesis

Planners, faculty and any other individuals in control of content not listed have indicated that they have no relevant financial relationships to disclose for this activity.

Manish K. Aghi, MD, PhD, FAANS

Kaisorn Lee Chaichana, MD, FAANS

Alexandra J. Golby, MD, FAANS

Accreditation

The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The AANS designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity was published in 5/19/2020. Credit may be obtained until 5/19/2023.

Key:

Complete
Failed
Available
Locked
Manish K. Aghi, MD, PhD, FAANS Video
Open to view video.
Open to view video.
Daniel A. Orringer, MD, FAANS Video
Open to view video.
Open to view video.
Kaisorn L. Chaichana, MD, FAANS Video
Open to view video.
Open to view video.
Constantinos G. Hadjipanayis, MD, PhD, FAANS Video
Open to view video.
Open to view video.
Francesco DiMeco, MD, IFAANS Video
Open to view video.
Open to view video.
Andrew E. Sloan, MD, FAANS Video
Open to view video.
Open to view video.
Michael A. Vogelbaum, MD, PhD, FAANS Video
Open to view video.
Open to view video.
Alexandra J. Golby, MD, FAANS Presentation (NO AUDIO)
Open to view video.
Open to view video. This is a slide presentation only. No audio is available.
Evaluation
10 Questions
Quiz
10 Questions  |  2 attempts  |  8/10 points to pass
10 Questions  |  2 attempts  |  8/10 points to pass
Certificate
3.00 AMA PRA Category 1 CreditTM credits  |  Certificate available
3.00 AMA PRA Category 1 CreditTM credits  |  Certificate available